Literature DB >> 24817132

Antidiabetic activity of Sedum dendroideum: metabolic enzymes as putative targets for the bioactive flavonoid kaempferitrin.

Daniel Da Silva1, Livia Marques Casanova, Mariah Celestino Marcondes, Jair Machado Espindola-Netto, Larissa Pereira Paixão, Giany Oliveira De Melo, Patricia Zancan, Mauro Sola-Penna, Sônia Soares Costa.   

Abstract

The aim of this study was to evaluate the antidiabetic potential of a leaf extract and flavonoids from Sedum dendroideum (SD). Additionally, our goals were to establish a possible structure/activity relationship between these flavonoids and to assess the most active flavonoid on the glycolytic enzyme 6-phosphofructo-1-kinase (PFK). SD juice (LJ), a flavonoid-rich fraction (BF), and separately five flavonoids were evaluated intraperitoneally for their acute hypoglycemic activity in normal and streptozotocin-induced diabetic mice. First, the major flavonoids kaempferol 3,7-dirhamnoside or kaempferitrin (1), kaempferol 3-glucoside-7-rhamnoside (2), and kaempferol 3-neohesperidoside-7-rhamnoside (3) were tested. Then, the monoglycosides kaempferol 7-rhamnoside (5) and kaempferol 3-rhamnoside (6) were assayed to establish their structure/activity relationship. The effect of 1 on PFK was evaluated in skeletal muscle, liver, and adipose tissue from treated mice. LJ (400 mg/kg), BF (40 mg/kg), and flavonoid 1 (4 mg/kg) reduced glycemia in diabetic mice (120 min) by 52, 53, and 61%, respectively. Flavonoids 2, 3, 5, and 6 were inactive or showed little activity, suggesting that the two rhamnosyl moieties in kaempferitrin are important requirements. Kaempferitrin enhanced the PFK activity chiefly in hepatic tissue, suggesting that it is able to stimulate tissue glucose utilization. This result is confirmed testing kaempferitrin on C2C12 cell line, where it enhanced glucose consumption, lactate production, and the key regulatory glycolytic enzymes. The hypoglycemic activity of kaempferitrin depends on the presence of both rhamnosyl residues in the flavonoid structure when intraperitoneally administered. Our findings show for the first time that a flavonoid is capable of stimulating PFK in a model of diabetes and that kaempferitrin stimulates glucose-metabolizing enzymes. This study contributes to the knowledge of the mechanisms by which this flavonoid exerts its hypoglycemic activity.
© 2014 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  PFK; Sedum dendroideum; diabetes; flavonoids; kaempferitrin

Mesh:

Substances:

Year:  2014        PMID: 24817132     DOI: 10.1002/iub.1270

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  5 in total

Review 1.  Measuring key human carbohydrate digestive enzyme activities using high-performance anion-exchange chromatography with pulsed amperometric detection.

Authors:  Elizabeth Barber; Michael J Houghton; Rizliya Visvanathan; Gary Williamson
Journal:  Nat Protoc       Date:  2022-09-30       Impact factor: 17.021

2.  Antilipidemic and Hepatoprotective Effects of Ethanol Extract of Justicia spicigera in Streptozotocin Diabetic Rats.

Authors:  Marina Murillo-Villicaña; Ruth Noriega-Cisneros; Donovan J Peña-Montes; Maribel Huerta-Cervantes; Asdrubal Aguilera-Méndez; Christian Cortés-Rojo; Rafael Salgado-Garciglia; Rocío Montoya-Pérez; Héctor Riveros-Rosas; Alfredo Saavedra-Molina
Journal:  Nutrients       Date:  2022-05-06       Impact factor: 6.706

3.  Effects of the mycorrhizal fungus Ceratobasidium sp. AR2 on growth and flavonoid accumulation in Anoectochilus roxburghii.

Authors:  Ying Zhang; Yuanyuan Li; Shunxing Guo
Journal:  PeerJ       Date:  2020-01-16       Impact factor: 2.984

4.  Phytochemical Profile and Antioxidant and Antiproliferative Activity of Sedum dendroideum on Pterygium Fibroblasts.

Authors:  Paloma López-Montemayor; Judith Zavala; María Dolores Montalvo-Parra; Guillermo Isaac Guerrero-Ramírez; Karla Mayolo-Deloisa; Daniela Enriquez-Ochoa; Bernardo Martínez-García; Denise Loya-García; Alba Miriam Guerrero-Martínez; Jorge Eugenio Valdez-García
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-18       Impact factor: 2.629

5.  Preclinical efficacy of the novel competitive NAMPT inhibitor STF-118804 in pancreatic cancer.

Authors:  Jair Machado Espindola-Netto; Claudia C S Chini; Mariana Tarragó; Enfeng Wang; Shamit Dutta; Krishnendu Pal; Debabrata Mukhopadhyay; Mauro Sola-Penna; Eduardo N Chini
Journal:  Oncotarget       Date:  2017-06-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.